ischemic heart disease


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.
Related to ischemic heart disease: ischemic stroke, congestive heart failure

ischemic heart disease

 
1. heart disease that causes narrowing of coronary arteries, leading to inadequate blood supply to the myocardium.
2. heart disease that occurs as a result of inadequate blood supply to the myocardium, as in myocardial infarction and angina pectoris.

ischemic heart disease

[iskē′mik]
a pathological condition caused by lack of oxygen in cells of the myocardium.

ischemic heart disease

Ischemic disease Cardiology A condition characterized by impaired myocardial function due to ↓ blood flow through the coronary arteries 2º to CAD; IHD is the most common cause of death worldwide; its prevalence and incidence continues to ↑; the US death rate for CAD has ↓; the hospital discharge rates for acute MI has remained constant, in 1995, ±2.2 million Pts were discharged from US hospitals with IHD, of whom ±350,000 had new-onset angina. See Angina, Antiplatelet therapy, Balloon angioplasty, CABG, Stenting.

is·che·mic heart dis·ease

(is-kē'mik hahrt di-zēz')
A general term for diseases of the heart caused by insufficient blood supply to the myocardium, e.g., atherosclerotic coronary artery disease, angina pectoris, unstable angina, and myocardial infarction.
Synonym(s): ischaemic heart disease, ischaemic heart disease.

Ischemic heart disease

Insufficient blood supply to the heart muscle (myocardium).
Mentioned in: Myocarditis

is·che·mic heart dis·ease

(is-kē'mik hahrt di-zēz')
A general term for diseases of the heart caused by insufficient blood supply to the myocardium.
Synonym(s): ischaemic heart disease.
References in periodicals archive ?
Asked to speculate about the mechanisms underlying the association between the aging signs and ischemic heart disease, Dr.
Tybaerg-Hansen and her coworkers showed that the increased risk of ischemic heart disease associated with xanthelasma cannot be explained by serum cholesterol or triglyceride levels (BMJ 2011;343:d5497).
In the largest study to date of autologous BMC therapy in patients with chronic ischemic heart disease and LV dysfunction, we found no effect of therapy on prespecified end points," the authors wrote.
Results of both studies suggest that there are common determinants of pregnancy complications and ischemic heart disease, Dr.
Patients with ischemic heart disease (37% of the HF population) who received treatment with a beta-blocker (60% of the HF patients with ischemic heart disease) had the highest mortality when they received quinine, 16% higher than for similar patients who did not get quinine, after adjustment for age and HF severity This meant that for every 38 patients with this clinical profile treated with quinine, 1 died.
Subclinical hypothyroidism has been believed to predispose patients to cardiovascular disease for decades, but no adequately powered, randomized, controlled intervention trials have been performed to determine whether treatment of the condition actually Improves the risk for ischemic heart disease.
between 1998 and 2008 to evaluate the validity of the Framingham Risk Score (FRS) in predicting the incidence of ischemic heart disease in the study cohort.
If psoriasis was an independent risk factor for ischemic heart disease, the observed incidence of cardiac events would have been in excess of predicted," the researchers wrote in their poster.
An easy registration of presence of xanthelasmata along with age and sex makes it possible to assess the risk of myocardial infarction and ischemic heart disease and thus to make sure that people at increased risk are managed accordingly," wrote Ms.
In this setting, presence of xanthelasmata may be a useful predictor of underlying atherosclerotic disease, An easy registration of presence of xanthelasmata along with age and sex makes it possible to assess the risk of myocardial infarction and ischemic heart disease and thus to make sure that people at increased risk are managed accordingly with lifestyle changes and treatment to reduce low-density lipoprotein cholesterol," wrote Ms.
Overall, 42% had been diagnosed with ischemic heart disease, and 15% had heart failure.
professor and chairman of the Department of Medicine, Jefferson Medical College, Thomas Jefferson University, and principal investigator for the PEECH trial noted, "Results of the PEECH trial, specifically the greater benefit observed in ischemic heart failure patients, are consistent with prior studies of EECP in patients with ischemic heart disease, including a randomized trial in angina, several case-series controlled studies, and a large patient registry.